We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
+3.16%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
-$3.97M
(-0.33%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
84.89%
Top 10 Holdings %
Top 10 Hldgs %
41.33%
Holding
473
New
43
Increased
203
Reduced
78
Closed
131
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$867M |
| 2 |
Illumina
ILMN
|
+$133M |
| 3 |
iShares S&P 100 ETF
OEF
|
+$115M |
| 4 |
Northrop Grumman
NOC
|
+$72.7M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$123M |
| 2 |
Illinois Tool Works
ITW
|
+$97.4M |
| 3 |
Northern Trust
NTRS
|
+$25M |
| 4 |
Apple
AAPL
|
+$24.6M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$23.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Industrials | 10.05% |
| 3 | Communication Services | 9.84% |
| 4 | Financials | 9.78% |
| 5 | Technology | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
AstraZeneca
AZN
$262B
| $714K | 0.06% |
8,106
+1,366
| +20% | +$89.2K |
|
202
Morgan Stanley
MS
$338B
| $713K | 0.06% |
+14,360
| New | +$619K |
|
203
Pediatrix Medical
MD
$2.15B
| $708K | 0.06% |
11,734
+19
| +0.2% | +$1.13K |
|
204
Colgate-Palmolive
CL
$72.3B
| $686K | 0.06% |
13,870
+9,500
| +217% | +$705K |
|
205
Caterpillar
CAT
$411B
| $680K | 0.06% |
19,385
+16,196
| +508% | +$1.65M |
|
|
ALXN
206
DELISTED
Alexion Pharmaceuticals
ALXN
| $656K | 0.05% |
6,680
+4,861
| +267% | +$566K |
|
|
HA
207
DELISTED
Hawaiian Holdings, Inc.
HA
| $653K | 0.05% |
+15,292
| New | +$778K |
|
208
iShares US Pharmaceuticals ETF
IHE
$1.47B
| $652K | 0.05% |
12,600
| – | – |
|
|
TEF
209
DELISTED
Telefonica
TEF
| $651K | 0.05% |
79,805
+22,444
| +39% | +$201K |
|
|
BCR
210
DELISTED
CR Bard Inc.
BCR
| $631K | 0.05% |
12,368
-3,035
| -20% | -$901K |
|
211
TSMC
TSM
$2.11T
| $627K | 0.05% |
+48,487
| New | +$1.68M |
|
212
Zoetis
ZTS
$31.5B
| $625K | 0.05% |
10,021
+796
| +9% | +$47K |
|
213
Microchip Technology
MCHP
$43.1B
| $623K | 0.05% |
34,370
+14,874
| +76% | +$585K |
|
214
T-Mobile US
TMUS
$192B
| $621K | 0.05% |
19,608
+15,807
| +416% | +$1.03M |
|
215
Southwest Airlines
LUV
$22.3B
| $612K | 0.05% |
6,732
+2,436
| +57% | +$142K |
|
|
FITB
216
Fifth Third Bancorp
FITB
$52.1B
| $603K | 0.05% |
14,873
+4,249
| +40% | +$105K |
|
217
AGCO
AGCO
$8.7B
| $602K | 0.05% |
7,752
-17,850
| -70% | -$1.14M |
|
218
Federated Hermes
FHI
$4.38B
| $600K | 0.05% |
33,557
+13,957
| +71% | +$373K |
|
219
Argan
AGX
$8.12B
| $594K | 0.05% |
9,895
+5,620
| +131% | +$363K |
|
220
Jefferies Financial Group
JEF
$12.9B
| $570K | 0.05% |
11,945
-2,320
| -16% | -$52.9K |
|
221
Greif
GEF
$4.45B
| $565K | 0.05% |
3,129
-571
| -15% | -$32.3K |
|
222
Biogen
BIIB
$29.9B
| $536K | 0.04% |
1,976
+208
| +12% | +$55K |
|
223
GSK
GSK
$103B
| $534K | 0.04% |
9,902
+115
| +1% | +$6.13K |
|
224
Vanguard Dividend Appreciation ETF
VIG
$111B
| $530K | 0.04% |
35,480
+32,219
| +988% | +$2.96M |
|
225
Tronox
TROX
$1.01B
| $529K | 0.04% |
35,000
| – | – |
|
Similar funds
Cerity Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Cerity Partners held 473 positions worth $1.19B, down 0.33% from $1.2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Cerity Partners deployed $1.01B of net new capital in Q2 2017, opening 43 new positions and adding to 203 existing holdings. Its largest new stake was iShares MSCI Switzerland ETF: 472,666 shares worth $16.2M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 8.7% a quarter earlier, followed by Industrials and Communication Services.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $123M trimmed.
- Cerity Partners's largest Q2 2017 buy was iShares MSCI Switzerland ETF: 472,666 shares worth $16.2M.
- Cerity Partners added most to Berkshire Hathaway Class A in Q2 2017, an estimated $867M increase.
- Cerity Partners's biggest Q2 2017 reduction was Meta Platforms (Facebook), cutting an estimated $123M.
- Cerity Partners fully exited iShares MSCI ACWI ETF in Q2 2017, selling an estimated $23.5M.
- Cerity Partners's ten largest holdings make up 41% of its $1.19B portfolio in Q2 2017.
- Cerity Partners opened 43 new positions and closed 131 in Q2 2017.
- Cerity Partners's portfolio value fell 0.33% quarter-over-quarter to $1.19B.
Based on Cerity Partners's 13F filing for Q2 2017, filed 10 Aug 2017.